University of Pittsburgh Announces 9 U.S. Patents Issued to Pitt Innovators in September 2026
Pitt innovators were issued nine U.S. patents in September 2026. Featured patent: 12,746,258: Hydrogel... Read more
Pitt innovators were issued nine U.S. patents in September 2026. Featured patent: 12,746,258: Hydrogel... Read more
Pitt’s Senior Vice Chancellor for Research, Dr. Rob Rutenbar introduced MIT professor Robert Langer... Read more
Licensing Associate
Andy Daniel is a Licensing Associate at the Innovation Institute where he supports the commercialization of the University’s intellectual property by conducting technology assessments and facilitating licensing opportunities across a range of biomedical innovations. Most recently, he was a postdoctoral scholar in neurosurgery at the University of California, San Francisco (UCSF) and during that time, he also served as a technology analyst for UCSF Innovation Ventures. He is a registered Patent Agent and a co-inventor on multiple granted patents. He has co-authored more than 20 peer-reviewed publications in leading scientific journals, including Nature, and has contributed to the development of FDA-cleared technologies for neurosurgical planning. Dr. Daniel holds an M.S. and Ph.D. in Biomedical Engineering from Washington University in St. Louis and a B.S. in Biomedical Engineering from the Illinois Institute of Technology.
University of Pittsburgh
Powered by AI. Please verify important information.